Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells

Oncogene

Volumn 23, Issue 40, 2004, Pages 6769-6778

  Malavaud, Bernard ^a,b   Pedron, Sandrine ^a   Sordello, Sylvie ^a   Mazerolles, Catherine ^c   Billottet, Clotilde ^d   Thiery, Jean Paul ^d   Jouanneau, Jacqueline ^d   Plouët, Jean ^a,e  

^a CNRS   (France)

^b CHU RANGUEIL   (France)

^c CHU PURPAN   (France)

^d INSTITUT CURIE   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Angiogenesis; Anti idiotypic antibodies; Fibroblast growth factor; Tumor proliferation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2,2 DICYANOVINYL) 2 NITROPHENOL; ANTIIDIOTYPIC ANTIBODY; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1 AGONIST; FIBROBLAST GROWTH FACTOR RECEPTOR 2 AGONIST; UNCLASSIFIED DRUG; VASCULOTROPIN; WORTMANNIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BLADDER CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIMERIZATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADRENAL CORTEX; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; CAPILLARIES; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICE, NUDE; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 4644225263     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207135     Document Type: Article

References (30)

1. Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H and Prats AC. (1999). Mol. Cell. Biol., 19, 505-514.
2. Basilico C and Moscatelli D. (1992). Adv. Cancer Res., 59, 115-165.
3. Bikfalvi A, Klein S, Pintucci G and Rifkin DB. (1997). Endocr. Rev., 18, 26-45.
4. Billottet C, Janji B, Thiery JP and Jouanneau J. (2002). Oncogene, 21, 8128-8139.
5. Bugler B, Amalric F and Prats H. (1991). Mol. Cell. Biol., 11, 573-577.
6. Clary DO, Weskamp G, Austin LR and Reichardt LF. (1994). Mol. Biol. Cell, 5, 549-563.
7. Couraud PO and Strosberg AD. (1991). Biochem. Soc. Trans., 19, 147-151.
8. Gospodarowicz D. (1987). Int. J. Rad. Appl. Instrum. B, 14, 421-434.
9. Hutchings H, Maitre-Boube M, Tombran-Tink J and Plouet J. (2002). Biochem. Biophys. Res. Commun., 294, 764-769.
10. Jerne NK, Roland J and Cazenave PA. (1982). EMBO J., 1, 243-247.
11. Jonca F, Ortega N, Gleizes PE, Bertrand N and Plouet J. (1997). J. Biol. Chem., 272, 24203-24209.
12. Jouanneau J, Moens G and Thiery JP. (1999). Oncogene, 18, 327-333.
13. Jouanneau J, Plouet J, Moens G and Thiery JP. (1997). Oncogene, 14, 671-676.
14. Kudla AJ, Jones NC, Rosenthal RS, Arthur K, Clase KL and Olwin BB. (1998). J. Cell Biol., 142, 241-250.
15. Mignatti P, Morimoto T and Rifkin DB. (1991). Proc. Natl. Acad. Sci. USA, 88, 11007-11011.
16. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T and Kurokawa T. (1993). Mol. Cell. Biol., 13, 4251-4259.
17. Moscatelli D. (1992). J. Biol. Chem., 267, 25803-25809.
18. Okada-Ban M, Thiery JP and Jouanneau J. (2000). Int. J. Biochem. Cell. Biol., 32, 263-267.
19. Ortega N, Jonca F, Vincent S, Favard C, Ruchoux MM and Plouet J. (1997). Am. J. Pathol., 151, 1215-1224.
20. Ozaki H, Okamoto N, Ortega S, Chang M, Ozaki K, Sadda S, Vinores MA, Derevjanik N, Zack DJ, Basilico C and Campochiaro PA. (1998). Am. J. Pathol., 153, 757-765.
21. Plouet J and Gospodarowicz D. (1990). Exp. Eye Res., 51, 519-529.
22. Powers CJ, McLeskey SW and Wellstein A. (2000). Endocr. Relat. Cancer, 7, 165-197.
23. Quarto N and Amalric F. (1994). J. Cell Sci., 107, 3201-3212.
24. Rogelj S, Weinberg RA, Fanning P and Klagsbrun M. (1988). Nature, 331, 173-175.
25. Sato Y and Rifkin DB. (1988). J. Cell Biol., 107, 1199-1205.
26. Savagner P, Valles AM, Jouanneau J, Yamada KM and Thiery JP. (1994). Mol. Biol. Cell, 5, 851-862.
27. Schweigerer L, Neufeld G and Gospodarowicz D. (1987). J. Clin. Invest., 80, 1516-1520.
28. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB and Mignatti P. (1998). J. Cell Biol., 141, 1659-1673.
29. Soulet F, Al Saati T, Roga S, Amalric F and Bouche G. (2001). Biochem. Biophys. Res. Commun., 289, 591-596.
30. Wiedlocha A, Falnes PO, Madshus IH, Sandvig K and Olsnes S. (1994). Cell, 76, 1039-1051.